Summit Therapeutics EBIT 2015-2024 | SMMT
- Summit Therapeutics 2023 EBIT was -0.61B, a 745.69% increase from 2022.
- Summit Therapeutics 2022 EBIT was -0.072B, a 16.36% decline from 2021.
- Summit Therapeutics 2021 EBIT was -0.086B, a 62.03% increase from 2020.
EBIT can be defined as earnings before interest and taxes.